作者简介 刘蕊(1989-),女,药师,学士,研究方向:临床药学; E-mail:Li351227007@163.com。
were inserted into pGL3-basic, a luciferase reporter gene vector, to construct pGL3-MDR1Pn which were directed by MDR1 promoter. The different lengths of MDR1 promoter reporter gene vector pGL3-MDR1Pn and pRL-TK were co-transfected into MCF-7 cells or MCF-7/ADR cells in a certain proportion, where pGL3-control was a positive control. The transcriptional activity of MDR1 promoter at three different lengths in the two kinds of cells were compared by the luciferase activity. Results: The constructions of pGL3-MDR1Pn were determined by DNA sequencing. Compared with the positive control, the activities of pGL3-MDR1P1, pGL3-MDR1P2 and pGL3-MDR1P3 in MCF-7 were (13.03 2.35)%, (14.60 3.57)% and (10.27 1.89)%, respectively. But their activities in MCF-7/ADR were (105.26 6.84)%, (59.08 4.95)% and (62.39 5.76)%, respectively. Conclusion: The MDR1 promoter is cloned successfully and the luciferase reporter gene vectors pGL3-MDR1P are successfully constructed. These results show that MDR1P1 with 2000 bp may have higher specificity in MCF-7/ADR cells than that in MCF-7 cells.
[1]王清,刘倩,张学梅. P- 糖蛋白及其逆转肿瘤细胞多药耐药性的研究进展[J].中国执业药师,2013,10(3):33 [2]Binkha Thlan Z,LavasaNIFAR A. P - glycoprotein inhibitionas a therapeutic approach for overcoming multidrug resistancein cancer: current status and future perspectives[J].Curr Cancer Drug Targets,2013,13(3) : 326 [3]Wang X M, Li L, Cui Q, et al. Quantitative detection of peripheral MDR genes in breast cancer before chemotherapy and their clinical significances[J]. Chinese-German J Clinical Oncol , 2008,11(7):641 [4]王向玲,纪春岩,马道新,等. MDR1启动子驱动的CD-TK双自杀基因载体对耐药K562细胞的体外靶向杀伤作用[J].中华血液学杂志,2006,27(11):757 [5]王波,王志云,王成伟,等. MDR1启动子调控的双自杀基因靶向杀伤耐药胶质瘤细胞的研究[J].山东大学学报,2008,46(1):15 [6] Labialle S, Gayet L, Marthinet E, , et al. Transcriptional regulators of the human multidrug resistance 1 gene,recent views[J]. Biochem Pharmacol ,2002,64(5/6):943 [7]贺赛,孙学军,郑见宝,等. hTERT,CEA 及CMV 启动子在人结肠癌细胞株中 的转录活性比较[J]. 中国普通外科杂志,2014,23(1):78 [8]林燕真,程通,张雅丽,等. 肿瘤细胞特异启动子hTERT介导的靶向MDR1基因的RNAi用于逆转卵巢癌细胞MDR的研究[J].中国医学创新,2015,12(34):9 [9]Ogretmen B, Ahmad R S. Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region [J]. Biochemistry,1999,38(7):2189 [10]李长龙,萨晓婴. MDR1基因单靶点双荧光素酶报告基因系统的建立[J].中国比较医学杂志,2008,18(9):28 [12]李海平,高波,余宗涛. MDR1基因的表达与肝癌生物学行为指标的关系[J].现代肿瘤医学,2013,21(1):129 [13]况守龙,胡廷章.启动子的克隆和研究方法[J].重庆工学院学报,2007,21(1):136 [14]Greer L F 3rd, Szalay A A. Imaging of light emission from the expression of luciferases in living cells and organisms: a review[J]. Luminescence, 2002,17(1):43 [15]吴胜昔,陈永文,朱广倍,等.B7-H1启动子荧光素酶报告基因载体的构建及活性检测[J].基础医学与临床,2014,34(7):957[11]Tesshi Yamada,Asako S T,Yasuyoshi Naishiro, et al. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in earlycolorectal carcinogenesis[J]. Cancer Res. 2000, 60(17):4761